PagnatoKarp Partners’s Teva Pharmaceuticals TEVA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-13,915	Closed	-$245K	–	136
2017 Q3	$245K	Buy	13,915 +3,206	+30%	+$56.4K	0.06%	116
2017 Q2	$356K	Buy	10,709 +2,988	+39%	+$99.3K	0.11%	102
2017 Q1	$248K	Buy	+7,721	New	+$248K	0.07%	109